ALK and non-small cell lung carcinoma: Especially, anaplastic lymphocyte kinase (ALK) is a well-known receptor tyrosine kinase in NSCLC as well as in BM; BMs are found in 20–40% of patients with ALK-rearranged NSCLCs [9].